United States, April 23 -- Accenture has invested, through Accenture Ventures, in Iridius, an enterprise AI infrastructure company that designs compliant-by-design AI solutions for highly regulated industries, including life sciences and pharmaceuticals sectors. As part of this investment, Accenture and Iridius will also form a strategic partnership to support life sciences organizations in scaling AI adoption while ensuring compliance, traceability, and auditability are integrated at every stage.The collaboration will combine Accenture's deep industry knowledge and delivery scale with AI-powered regulatory and compliance capabilities from Iridius, enabling clients to move beyond isolated AI pilots and achieve enterprise-wide, compliant AI ...